Global Gastric Cancer Diagnostics Industry

2023-2029 Global Gastric Cancer Diagnostics Industry Research & Trends Analysis Report

Global Gastric Cancer Diagnostics Industry

2023-2029 Global Gastric Cancer Diagnostics Industry Research & Trends Analysis Report


Analysis of the Gastric Cancer Diagnostics Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Study , the global market for Gastric Cancer Diagnostics should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Gastric Cancer Diagnostics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Gastric Cancer Diagnostics market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Instrument segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Male has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Gastric Cancer Diagnostics include Myriad Genetics, ACON Laboratories, Teco Diagnostics, Vela Diagnostics, Abbott, AdvaCare Pharma, Fujirebio (An H.U. Group company), Thermo Fisher Scientific, F. Hoffmann-La Roche and General Electric, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Gastric Cancer Diagnostics. Report Highlights:

(1) Global Gastric Cancer Diagnostics market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Gastric Cancer Diagnostics market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Gastric Cancer Diagnostics market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Gastric Cancer Diagnostics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Gastric Cancer Diagnostics segment by type and by application and regional segment by type and by application.

(6) Gastric Cancer Diagnostics industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Instrument

Reagent Consumables

Service

Market segment by application, can be divided into

Male

Female

Market segment by players, this report covers

Myriad Genetics

ACON Laboratories

Teco Diagnostics

Vela Diagnostics

Abbott, AdvaCare Pharma

Fujirebio (An H.U. Group company)

Thermo Fisher Scientific

F. Hoffmann-La Roche

General Electric

Agilent Technologies

Endofotonics

Biohit Oyj

BIOCEPT

FOUNDATION MEDICINE

DiaSorin S.p.A

Paragon Genomics

BIOMÉRIEUX

QIAGEN

1 Market Overview

1.1 Product Overview and Scope of Gastric Cancer Diagnostics

1.2 Global Gastric Cancer Diagnostics Market Size and Forecast

1.3 China Gastric Cancer Diagnostics Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Gastric Cancer Diagnostics Share in Global Market, 2019-2030

1.4.2 Gastric Cancer Diagnostics Market Size: China VS Global, 2019-2030

1.5 Gastric Cancer Diagnostics Market Dynamics

1.5.1 Gastric Cancer Diagnostics Market Drivers

1.5.2 Gastric Cancer Diagnostics Market Restraints

1.5.3 Gastric Cancer Diagnostics Industry Trends

1.5.4 Gastric Cancer Diagnostics Industry Policy

2 Global Competitive Situation by Company

2.1 Global Gastric Cancer Diagnostics Revenue by Company (2019-2024)

2.2 Global Gastric Cancer Diagnostics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Gastric Cancer Diagnostics Concentration Ratio

2.4 Global Gastric Cancer Diagnostics Mergers & Acquisitions, Expansion Plans

2.5 Global Gastric Cancer Diagnostics Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Gastric Cancer Diagnostics Revenue by Company (2019-2024)

3.2 China Gastric Cancer Diagnostics Gastric Cancer Diagnostics Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Gastric Cancer Diagnostics, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Gastric Cancer Diagnostics Industry Chain

4.2 Gastric Cancer Diagnostics Upstream Analysis

4.3 Gastric Cancer Diagnostics Midstream Analysis

4.4 Gastric Cancer Diagnostics Downstream Analysis

5 Sights by Type

5.1 Gastric Cancer Diagnostics Classification

5.1.1 Instrument

5.1.2 Reagent Consumables

5.1.3 Service

5.2 By Type, Global Gastric Cancer Diagnostics Market Size & CAGR, 2019 VS 2023 VS 2030

5.3 By Type, Global Gastric Cancer Diagnostics Revenue, 2019-2030

6 Sights by Application

6.1 Gastric Cancer Diagnostics Segment by Application

6.1.1 Male

6.1.2 Female

6.2 By Application, Global Gastric Cancer Diagnostics Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Application, Global Gastric Cancer Diagnostics Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Gastric Cancer Diagnostics Market Size, 2019 VS 2023 VS 2030

7.2 By Region, Global Gastric Cancer Diagnostics Market Size, 2019-2030

7.3 North America

7.3.1 North America Gastric Cancer Diagnostics Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Gastric Cancer Diagnostics Market Size Market Share

7.4 Europe

7.4.1 Europe Gastric Cancer Diagnostics Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Gastric Cancer Diagnostics Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Gastric Cancer Diagnostics Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Gastric Cancer Diagnostics Market Size Market Share

7.6 South America

7.6.1 South America Gastric Cancer Diagnostics Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Gastric Cancer Diagnostics Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Gastric Cancer Diagnostics Market Size & CAGR，2019 VS 2023 VS 2030

8.2 By Country, Global Gastric Cancer Diagnostics Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Gastric Cancer Diagnostics Market Size, 2019-2030

8.3.2 By Company, U.S. Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Gastric Cancer Diagnostics Market Size, 2019-2030

8.4.2 By Company, Europe Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Gastric Cancer Diagnostics Market Size, 2019-2030

8.5.2 By Company, China Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.5.3 By Type, China Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Gastric Cancer Diagnostics Market Size, 2019-2030

8.6.2 By Company, Japan Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Gastric Cancer Diagnostics Market Size, 2019-2030

8.7.2 By Company, South Korea Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Gastric Cancer Diagnostics Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Gastric Cancer Diagnostics Market Size, 2019-2030

8.9.2 By Company, India Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.9.3 By Type, India Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Gastric Cancer Diagnostics Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Gastric Cancer Diagnostics Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Gastric Cancer Diagnostics Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Myriad Genetics

9.1.1 Myriad Genetics Company Information, Head Office, Market Area and Industry Position

9.1.2 Myriad Genetics Company Profile and Main Business

9.1.3 Myriad Genetics Gastric Cancer Diagnostics Models, Specifications and Application

9.1.4 Myriad Genetics Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.1.5 Myriad Genetics Recent Developments

9.2 ACON Laboratories

9.2.1 ACON Laboratories Company Information, Head Office, Market Area and Industry Position

9.2.2 ACON Laboratories Company Profile and Main Business

9.2.3 ACON Laboratories Gastric Cancer Diagnostics Models, Specifications and Application

9.2.4 ACON Laboratories Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.2.5 ACON Laboratories Recent Developments

9.3 Teco Diagnostics

9.3.1 Teco Diagnostics Company Information, Head Office, Market Area and Industry Position

9.3.2 Teco Diagnostics Company Profile and Main Business

9.3.3 Teco Diagnostics Gastric Cancer Diagnostics Models, Specifications and Application

9.3.4 Teco Diagnostics Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.3.5 Teco Diagnostics Recent Developments

9.4 Vela Diagnostics

9.4.1 Vela Diagnostics Company Information, Head Office, Market Area and Industry Position

9.4.2 Vela Diagnostics Company Profile and Main Business

9.4.3 Vela Diagnostics Gastric Cancer Diagnostics Models, Specifications and Application

9.4.4 Vela Diagnostics Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.4.5 Vela Diagnostics Recent Developments

9.5 Abbott, AdvaCare Pharma

9.5.1 Abbott, AdvaCare Pharma Company Information, Head Office, Market Area and Industry Position

9.5.2 Abbott, AdvaCare Pharma Company Profile and Main Business

9.5.3 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Models, Specifications and Application

9.5.4 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.5.5 Abbott, AdvaCare Pharma Recent Developments

9.6 Fujirebio (An H.U. Group company)

9.6.1 Fujirebio (An H.U. Group company) Company Information, Head Office, Market Area and Industry Position

9.6.2 Fujirebio (An H.U. Group company) Company Profile and Main Business

9.6.3 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Models, Specifications and Application

9.6.4 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.6.5 Fujirebio (An H.U. Group company) Recent Developments

9.7 Thermo Fisher Scientific

9.7.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

9.7.2 Thermo Fisher Scientific Company Profile and Main Business

9.7.3 Thermo Fisher Scientific Gastric Cancer Diagnostics Models, Specifications and Application

9.7.4 Thermo Fisher Scientific Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.7.5 Thermo Fisher Scientific Recent Developments

9.8 F. Hoffmann-La Roche

9.8.1 F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

9.8.2 F. Hoffmann-La Roche Company Profile and Main Business

9.8.3 F. Hoffmann-La Roche Gastric Cancer Diagnostics Models, Specifications and Application

9.8.4 F. Hoffmann-La Roche Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.8.5 F. Hoffmann-La Roche Recent Developments

9.9 General Electric

9.9.1 General Electric Company Information, Head Office, Market Area and Industry Position

9.9.2 General Electric Company Profile and Main Business

9.9.3 General Electric Gastric Cancer Diagnostics Models, Specifications and Application

9.9.4 General Electric Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.9.5 General Electric Recent Developments

9.10 Agilent Technologies

9.10.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position

9.10.2 Agilent Technologies Company Profile and Main Business

9.10.3 Agilent Technologies Gastric Cancer Diagnostics Models, Specifications and Application

9.10.4 Agilent Technologies Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.10.5 Agilent Technologies Recent Developments

9.11 Endofotonics

9.11.1 Endofotonics Company Information, Head Office, Market Area and Industry Position

9.11.2 Endofotonics Company Profile and Main Business

9.11.3 Endofotonics Gastric Cancer Diagnostics Models, Specifications and Application

9.11.4 Endofotonics Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.11.5 Endofotonics Recent Developments

9.12 Biohit Oyj

9.12.1 Biohit Oyj Company Information, Head Office, Market Area and Industry Position

9.12.2 Biohit Oyj Company Profile and Main Business

9.12.3 Biohit Oyj Gastric Cancer Diagnostics Models, Specifications and Application

9.12.4 Biohit Oyj Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.12.5 Biohit Oyj Recent Developments

9.13 BIOCEPT

9.13.1 BIOCEPT Company Information, Head Office, Market Area and Industry Position

9.13.2 BIOCEPT Company Profile and Main Business

9.13.3 BIOCEPT Gastric Cancer Diagnostics Models, Specifications and Application

9.13.4 BIOCEPT Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.13.5 BIOCEPT Recent Developments

9.14 FOUNDATION MEDICINE

9.14.1 FOUNDATION MEDICINE Company Information, Head Office, Market Area and Industry Position

9.14.2 FOUNDATION MEDICINE Company Profile and Main Business

9.14.3 FOUNDATION MEDICINE Gastric Cancer Diagnostics Models, Specifications and Application

9.14.4 FOUNDATION MEDICINE Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.14.5 FOUNDATION MEDICINE Recent Developments

9.15 DiaSorin S.p.A

9.15.1 DiaSorin S.p.A Company Information, Head Office, Market Area and Industry Position

9.15.2 DiaSorin S.p.A Company Profile and Main Business

9.15.3 DiaSorin S.p.A Gastric Cancer Diagnostics Models, Specifications and Application

9.15.4 DiaSorin S.p.A Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.15.5 DiaSorin S.p.A Recent Developments

9.16 Paragon Genomics

9.16.1 Paragon Genomics Company Information, Head Office, Market Area and Industry Position

9.16.2 Paragon Genomics Company Profile and Main Business

9.16.3 Paragon Genomics Gastric Cancer Diagnostics Models, Specifications and Application

9.16.4 Paragon Genomics Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.16.5 Paragon Genomics Recent Developments

9.17 BIOMÉRIEUX

9.17.1 BIOMÉRIEUX Company Information, Head Office, Market Area and Industry Position

9.17.2 BIOMÉRIEUX Company Profile and Main Business

9.17.3 BIOMÉRIEUX Gastric Cancer Diagnostics Models, Specifications and Application

9.17.4 BIOMÉRIEUX Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.17.5 BIOMÉRIEUX Recent Developments

9.18 QIAGEN

9.18.1 QIAGEN Company Information, Head Office, Market Area and Industry Position

9.18.2 QIAGEN Company Profile and Main Business

9.18.3 QIAGEN Gastric Cancer Diagnostics Models, Specifications and Application

9.18.4 QIAGEN Gastric Cancer Diagnostics Revenue and Gross Margin, 2019-2024

9.18.5 QIAGEN Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Gastric Cancer Diagnostics Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Gastric Cancer Diagnostics Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the market value of the Gastric Cancer Diagnostics Industry?
In 2024, the Gastric Cancer Diagnostics Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What does the future hold for the Gastric Cancer Diagnostics Market?
As the shift to value addition continues, companies in the Gastric Cancer Diagnostics Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the estimated global market value of the Gastric Cancer Diagnostics Market?
The Gastric Cancer Diagnostics Market is expected to reach a considerable market valuation.